HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Revenue

HLS Therapeutics had revenue of $14.17M USD in the quarter ending June 30, 2025, a decrease of -2.40%. This brings the company's revenue in the last twelve months to $56.42M, down -4.20% year-over-year. In the year 2024, HLS Therapeutics had annual revenue of $56.62M, down -10.23%.

• Revenue (ttm): $56.42M
• Revenue Growth: -4.20%
• P/S Ratio: 2.13
• Revenue / Employee: $613.27K
• Employees: 92
• Market Cap: 163.88M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	56.62M	-6.46M	-10.23%
Dec 31, 2023	63.07M	1.61M	2.61%
Dec 31, 2022	61.47M	1.46M	2.43%
Dec 31, 2021	60.01M	3.90M	6.95%
Dec 31, 2020	56.11M	1.95M	3.60%